NOVOZYMES A/S SPONS.ADR 1 (NZM) — Cash Flow-to-Debt Ratio
NOVOZYMES A/S SPONS.ADR 1 (NZM) has a Cash Flow-to-Debt Ratio of 0.03x as of March 2026, meaning its operating cash flow of €167.10 Million could theoretically repay 0% of its total liabilities (€5.60 Billion) in one year. See NZM free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
NOVOZYMES A/S SPONS.ADR 1 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for NOVOZYMES A/S SPONS.ADR 1 across 5 annual periods. Also explore NOVOZYMES A/S SPONS.ADR 1 annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for NOVOZYMES A/S SPONS.ADR 1 (2021–2025)
Year-by-year debt coverage analysis for NOVOZYMES A/S SPONS.ADR 1. For market capitalisation and broader financial context, see NZM company net worth.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | €1.22 Billion | €5.49 Billion | ▼ -12.4% |
| 2024 | 0.25x | €1.02 Billion | €4.02 Billion | ▼ -14.2% |
| 2023 | 0.30x | €557.10 Million | €1.88 Billion | ▲ +1.5% |
| 2022 | 0.29x | €537.65 Million | €1.85 Billion | ▼ -9.9% |
| 2021 | 0.32x | €546.17 Million | €1.69 Billion | — |